Allina, nurses contest each other's resolve as strike enters third week | (Minneapolis) Star-Tribune
Allina Health and its striking nurses challenged each other's staying power on Monday as the nurses' walkout reached its third week without a deal — or further talks — in sight.
Erlanger employees get $400 bonuses as hospital again has a profitable year | The Chattanoogan
The 3,700 Erlanger Health System, Chattanooga, Tenn., employees will get $400 bonuses as the once-ailing hospital again had a profitable year. Britt Tabor, Erlanger chief financial officer, said the bonuses will be included in checks in early October.
Independent doctors call reimbursement plan a 'shell game' | VTDigger.org
The chief medical officer for an independent practice organization says it's possible to lower prices paid to the University of Vermont Medical Center by 3% and use that money to increase pay to independent doctors by 25%.
Operating-room machines test positive for Legionella at UW Medicine | Seattle Times
Bacteria that cause Legionnaires' disease have been detected in University of Washington Medical devices used to heat and cool patients during heart surgery, the same type of machines linked to different types of deadly outbreaks in other hospitals.
Lahey Health teams up with Boston Bruins | Boston Globe
Burlington, Mass.-based Lahey Health will be the official health care partner of the Boston Bruins, the hockey team announced Monday as it unveiled a five-year partnership covering advertising, medical care and charity events. The agreement supersedes a previous deal with Hallmark Health System of Medford.
FDA wants an app to help solve opiate overdoses | Gizmodo.com
Among the many ways to combat a drug epidemic, an app competition is easily the strangest. The Naloxone App Competition is open to the public and registration doesn't open until Oct. 7, so details on what such an app would look like and what it would do are thin.
Mylan CEO's boss, the man who acquired Epipen, avoids spotlight | Bloomberg.com
Heather Bresch will face the proverbial lash from Congress on Wednesday over the escalating cost of Mylan's EpiPen. Her boss won't.